The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

MLA

Souzi Makri, et al. The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases. Jan. 2020. EBSCOhost, https://doi.org/10.1007/s40265-020-01256-5⟩.

APA

Souzi Makri, Steven Simoens, Ben Parker, JongHyuk Lee, Laurent Peyrin-Biroulet, Jonas Halfvarson, Kay Greveson, Jørgen Jahnsen, Rieke Alten, Rene Westhovens, Peter L. Lakatos, Silvio Danese, Fernando Gomollón, Stefan Schreiber, Peter M. Irving, HoUng Kim, Ji Hoon Jeong, Luisa Avedano, & Axel Dignass. (2020). The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases. https://doi.org/10.1007/s40265-020-01256-5⟩

Chicago

Souzi Makri, Steven Simoens, Ben Parker, JongHyuk Lee, Laurent Peyrin-Biroulet, Jonas Halfvarson, Kay Greveson, et al. 2020. “The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases,” January. doi:10.1007/s40265-020-01256-5⟩.